TM
ACAD icon

Torren Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Torren Management’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$278 Hold
11
– – ﹤0.01% 902
2026
Q1 		$245 Sell
11
-147
-93% -$3.51K ﹤0.01% 939
2025
Q4 		$4.22K Buy
+158
New +$3.78K ﹤0.01% 938

Other funds holding ACAD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Torren Management's ACAD Position: Q2 2026 in Review

Torren Management held its Acadia Pharmaceuticals (ACAD) position steady in Q2 2026 at 11 shares worth $278. The position accounts for ﹤0.01% of the portfolio, ranked #902.

Torren Management first reported a position in ACAD in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.22K in Q4 2025. 138 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • Torren Management held 11 shares of Acadia Pharmaceuticals worth $278 as of Q2 2026.
  • Torren Management left its Acadia Pharmaceuticals share count unchanged in Q2 2026.
  • Acadia Pharmaceuticals made up ﹤0.01% of Torren Management's portfolio in Q2 2026, its #902 holding.
  • Torren Management first reported a position in Acadia Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Torren Management's Acadia Pharmaceuticals position peaked at $4.22K in Q4 2025.
  • 138 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on Torren Management's 13F filing for Q2 2026, filed 10 Jul 2026.